Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Long-term use of ticagrelor in patients with prior myocardial infarction.

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators.

N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14.

2.

Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patterns.

Bueno H, Sinnaeve P, Annemans L, Danchin N, Licour M, Medina J, Pocock S, Sánchez-Covisa J, Storey RF, Jukema JW, Zeymer U, Van de Werf F; EPICOR Investigators.

Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):3-12. doi: 10.1177/2048872614565912. Epub 2015 Jan 5.

PMID:
25561688
3.

[ANMCO/SICI-GISE document on antiplatelet therapy in patients with acute coronary syndrome].

De Luca L, Bolognese L, Valgimigli M, Ceravolo R, Danzi GB, Piccaluga E, Rakar S, Cremonesi A, Bovenzi FM; Gruppo di Lavoro dell'Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Societa Italiana di Cardiologia Invasiva (SICI-GISE).

G Ital Cardiol (Rome). 2013 Dec;14(12):839-66. doi: 10.1714/1371.15242. Italian.

PMID:
24336601
4.

A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).

Ribichini F, Romano M, Rosiello R, La Vecchia L, Cabianca E, Caramanno G, Milazzo D, Loschiavo P, Rigattieri S, Musarò S, Pironi B, Fiscella A, Amico F, Indolfi C, Spaccarotella C, Bartorelli A, Trabattoni D, Della Rovere F, Rolandi A, Beqaraj F, Belli R, Sangiorgio P, Villani R, Berni A, Sheiban I, Lopera Quijada MJ, Cappi B, Ribaldi L, Vassanelli C; EXECUTIVE Trial Investigators.

JACC Cardiovasc Interv. 2013 Oct;6(10):1012-22. doi: 10.1016/j.jcin.2013.05.016. Epub 2013 Sep 18.

5.

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators.

N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.

6.

Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.

Borghi C, Ambrosioni E, Omboni S, Cicero AF, Bacchelli S, Esposti DD, Vinereanu D, Ambrosio G, Zava D; SMILE-4 Working Party.

J Hypertens. 2013 Jun;31(6):1256-64. doi: 10.1097/HJH.0b013e3283605cd8.

PMID:
23552127
8.

Differences in cardiovascular risk factors and clinical outcomes between Western European and Southeast Asian patients treated with the Genous Bio-engineered R stent: an e-HEALING worldwide registry substudy.

Klomp M, Damman P, Beijk MA, Tan KH, Balian V, de Luca G, Tijssen JG, Silber S, de Winter RJ; e-HEALING investigators.

Coron Artery Dis. 2012 Jun;23(4):271-7. doi: 10.1097/MCA.0b013e328351aaed.

PMID:
22473083
9.

Vorapaxar in the secondary prevention of atherothrombotic events.

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators.

N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24.

10.

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW; TRACER Investigators.

N Engl J Med. 2012 Jan 5;366(1):20-33. doi: 10.1056/NEJMoa1109719. Epub 2011 Nov 13.

11.

Rivaroxaban in patients with a recent acute coronary syndrome.

Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2–TIMI 51 Investigators.

N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13.

12.

[Transient ST-segment elevation due to iatrogenic pneumopericardium].

Azzarelli S, Amico F, Giacoppo M, Argentino V, Fiscella D, Fiscella A.

G Ital Cardiol (Rome). 2011 Mar;12(3):217-8. Italian. No abstract available.

PMID:
21560479
13.

Iatrogenic left main coronary artery dissection: a single-center case series.

Azzarelli S, Amico F, Giacoppo M, Argentino V, Fiscella A.

J Cardiovasc Med (Hagerstown). 2011 Aug;12(8):592-4. doi: 10.2459/JCM.0b013e328345ad34. No abstract available.

PMID:
21558876
14.

Clinical and angiographic outcomes in elderly patients treated with endothelial progenitor cell capture coronary stents: results from a prospective single-center registry.

Azzarelli S, Galassi AR, Grosso G, Tomasello D, Campisano B, Giacoppo M, Argentino V, Amico F, Fiscella A.

J Invasive Cardiol. 2010 Dec;22(12):594-8.

15.

A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial.

Ribichini F, Ansalone G, Bartorelli A, Beqaraj F, Berni A, Colangelo S, D'Amico M, Della Rovere F, Fiscella A, Gabrielli G, Indolfi C, La Vecchia L, Loschiavo P, Marinoni G, Marzocchi A, Milazzo D, Romano M, Sangiorgio P, Sheiban I, Tamburino C, Tuccillo B, Villani R, Cappi B, Quijada MJ, Vassanelli C; EXECUTIVE Trial Investigators.

J Cardiovasc Med (Hagerstown). 2010 Apr;11(4):299-309. doi: 10.2459/JCM.0b013e3283331e69.

PMID:
20090550
16.

Thin strut chrome-cobalt stent implantation for treatment of de-novo lesions in small coronary vessels: results of the RISICO Italian Registry (Registro Italiano Mini VISION nei piccolo Vasi) utilizing the Mini VISION coronary stent platform.

Brambilla N, Morici N, Bedogni F, De Benedictis M, Scrocca I, Naldi M, Fiscella A, Prosperi F, Dominici M, Rebuzzi A, Colombo A, Sangiorgi GM; RISICO investigators.

J Cardiovasc Med (Hagerstown). 2009 Nov;10(11):852-8. doi: 10.2459/JCM.0b013e32832e6446.

PMID:
19550353
17.

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.

Mega JL, Braunwald E, Mohanavelu S, Burton P, Poulter R, Misselwitz F, Hricak V, Barnathan ES, Bordes P, Witkowski A, Markov V, Oppenheimer L, Gibson CM; ATLAS ACS-TIMI 46 study group.

Lancet. 2009 Jul 4;374(9683):29-38. doi: 10.1016/S0140-6736(09)60738-8. Epub 2009 Jun 17.

PMID:
19539361
18.

Multivessel spontaneous coronary artery dissection in a postpartum woman treated with multiple drug-eluting stents.

Azzarelli S, Fiscella D, Amico F, Giacoppo M, Argentino V, Fiscella A.

J Cardiovasc Med (Hagerstown). 2009 Apr;10(4):340-3. doi: 10.2459/JCM.0b013e3283276dee.

PMID:
19430346
19.
20.

Apical thrombus in a patient with takotsubo cardiomyopathy.

Azzarelli S, Galassi AR, Amico F, Giacoppo M, Argentino V, Giordano G, Fiscella A.

J Cardiovasc Med (Hagerstown). 2008 Aug;9(8):831-3. doi: 10.2459/JCM.0b013e3282f1938b.

PMID:
18607250
Items per page

Supplemental Content

Loading ...
Write to the Help Desk